MedPath

VIRTUAL REALITY TECHNOLOGY FOR CEREBRAL PALSY

Not Applicable
Not yet recruiting
Conditions
Cerebral Palsy
Registration Number
NCT05872217
Lead Sponsor
Cairo University
Brief Summary

The VRapeutic (Full-immersive game-based therapy) is new therapeutic Egyptian software. It has the potential to provide intensive, repetitive, and task-oriented training. It may increase children's motivation, enjoyment, active social participation. Children with UCP may experience varieties of associated health conditions as difficulty of movement, instability of postural balance, difficulty of motor planning and control which impact on UE function.

Detailed Description

Ethical statement this study was approved by institutional Review Board of the faculty of physical therapy ,cairo university .Egypt (no.P.T.REC/012/004237) .

Study Design A prospective randomized controlled trial of pre-post study design with two months follow-up evaluation will be used.

Sample size estimation

will be conducted to determine the number of recruited children. G\*POWER statistical software (version 3.1.9.2) will be used using α=0.05, power 80% allocation ratio N2/N1 =1.

Randomization The selected children will be assigned by simple randomization via closed envelopes into two equal groups (control and study); the envelope will be contained a letter indicating whether the child will be assigned to the control or to the study group.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • • Their ages will range from of 6 to 10 years.

    • Both genders will be included.
    • Their degree of spasticity will range from 1 to 1+ according to the Modified Ashworth Scale (Meseguer et al., 2018).
    • Their motor function will be at level I according to Gross Motor Function Classification System (Palisano et al., 2008).
    • They will be able to understand and follow the instructions.
Exclusion Criteria
  • Exclusion Criteria:

Children will be excluded from the study if they have any of the following criteria:

  • Epilepsy.
  • Visual or hearing problems.
  • Musculoskeletal fixed deformity in upper limbs, lower limbs or spine.
  • Orthopedic surgery on the involved UE.
  • Botulinum toxin therapy for the affected UE within the past 6 months or within the study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
rang of motionperiod of treatment will be 2 succssive months

The IMU sensors will be used to detect changes in angular displacement of child arm, forearm (which allow 3D analysis of movements in three planes X.Y.Z), speed and direction.

Placement of Sensors: Two sensors will be placed on the affected side, one around the arm distal to shoulder joint and the other around the forearm distal to elbow joint. The third sensor will be placed around the trunk.

The child will be in standing position with head in neutral position, trunk erect. The examiner will ask the child to perform functional task in form of (reaching forward toward targets placed on wall in multilevel, hand over head).

• ABILHAND-Kids questionnaireperiod of treatment will be 2 succssive months

will be administrated on an interview basis, the child will be asked to estimate their perception of the level of difficulty that faces during the performance of each activity in the list on a three-point ordinal scale of impossible, difficult, easy. Activities will be presented in random order to avoid any systematic effect. Activities not attempted in the last 3 months are not scored and are entered as missing responses (tick the question mark).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Physical Therapy

🇪🇬

Giza, Egypt

Faculty of Physical Therapy
🇪🇬Giza, Egypt
Somaya E Sherif
Contact
01062661942
somaya.sherif@cu.edu.eg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.